Please login to the form below

Not currently logged in
Email:
Password:

adverse events

This page shows the latest adverse events news and features for those working in and with pharma, biotech and healthcare.

More encouraging data for Spark and Pfizer’s potential haemophilia B cure

More encouraging data for Spark and Pfizer’s potential haemophilia B cure

None of the 15 experienced serious adverse events, and there were no thrombotic events or factor IX inhibitors, as of the 7 May, 2018 data cutoff. ... of SPK-9001 has resulted in dramatic reductions in bleeding and factor IX infusions, with no serious

Latest news

More from news
Approximately 5 fully matching, plus 328 partially matching documents found.

Latest Intelligence

  • A new era of smart pharma A new era of smart pharma

    Remote monitoring has its place but sponsors must still be able to collect detailed information on clinical endpoints, serious adverse events (SAEs) and events of special interest. ... SAEs). It is in this area that pharmacovigilance, the science

  • The tipping point The tipping point

    When conditioned to expect a negative response, otherwise known as the ‘nocebo’effect, patients are more likely to report adverse events, putting a brake on biosimilar adoption.

  • Gene therapy Gene therapy

    Because of his death, 652 previously unreported, serious adverse events, including deaths, were reported to the US National Institute of Health. ... As many of these trials were performed on very sick patients, it is unclear how many of these events can

  • Avoiding data pitfalls in clinical research Avoiding data pitfalls in clinical research

    When these algorithms are layered on traditional clinical data, sponsors can quickly identify changes in adverse events or therapeutic response. ... This is a deceptively difficult task, but once patient IDs are matched within the clinical trial database,

  • AI’s potential in the pharma life cycle AI’s potential in the pharma life cycle

    As more and more companies identify opportunities to turn AI-enabled insights into timely and beneficial outcomes - whether by accelerating market entry, successfully mining social media for potential adverse events and

More from intelligence
Approximately 0 fully matching, plus 14 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics